The Leadership Team at Spirovant Sciences is responsible for shaping the strategic direction and overall vision of the company as it develops innovative gene therapies for cystic fibrosis and other pulmonary diseases. Comprising experts in development, technology, medicine, and research, the team collaborates to drive scientific advancements, oversee clinical progress, and foster partnerships that enhance the company’s mission of improving patient outcomes.
View all